METAVEX 225 mg/1
METAVEX · TABLET · Oncora Pharma, LLC
METAVEX is a tablet containing metavex at 225 mg/1, taken oral. Manufactured by Oncora Pharma, LLC.
Key Facts
- Brand Name
- METAVEX
- Generic Name
- METAVEX
- NDC Code (Product)
85477-503- Manufacturer
- Oncora Pharma, LLC
- Strength
- 225 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Drug Class
- Vitamin D [EPC]
- Marketing Start
- 01/01/2026
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Metavex™ is indicated as a prescription dietary supplement for the dietary management of individuals with metabolic health needs where folic acid supplementation is appropriate. Administration: Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.
Dosage & Administration
DOSAGE AND ADMINISTRATION Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.
Warnings
WARNINGS Metavex™ should be administered under the supervision of a licensed medical practitioner. Patients should not exceed the recommended dosage. If adverse reactions occur, discontinue use and consult a healthcare professional.
Contraindications
CONTRAINDICATIONS Metavex™ is contraindicated in patients with known hypersensitivity to any of its components.
Frequently Asked Questions
What is METAVEX used for?
METAVEX contains METAVEX. It is a tablet taken oral. Consult your doctor for specific uses.
Is METAVEX a controlled substance?
METAVEX is not classified as a controlled substance by the DEA.
What is the generic name for METAVEX?
The generic name for METAVEX is METAVEX. There are no other listed brand versions of METAVEX.
What is the NDC code for METAVEX 225 mg/1?
The NDC (National Drug Code) for METAVEX 225 mg/1 is 85477-503, listed by Oncora Pharma, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)